Cagrilintide (5 mg Vial)
This reference covers Cagrilintide (5 mg Vial) in vial format: reconstitution steps, the concentration each volume produces, syringe-unit conversions and storage conditions for the lyophilized and reconstituted material.
CAT No:
CAS No:
Synonyms/Alias:Cagrilintide
M.F/Formula:
M.W/Mr.:
Purity:Specification by inquiry
- Sequence, purity and scale confirmation
- CoA and technical documentation requests
- API, research and cosmetic peptide options
- Distributor and institution quotation support
This reference covers Cagrilintide (5 mg Vial) in vial format: reconstitution steps, the concentration each volume produces, syringe-unit conversions and storage conditions for the lyophilized and reconstituted material.
Quickstart
Reconstitute: Add 3.0 mL bacteriostatic water → ~ 1.67 mg/mL concentration.
Typical weekly range: 0.6–4.5 mg once weekly (gradual titration over 4–6 weeks).
Easy measuring: At 1.67 mg/mL, 1 unit = 0.01 mL ≈ 0.0167 mg (16.7 mcg) on a U‑100 insulin syringe.
Storage: Lyophilized: store frozen at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) and use within 30 days.
Notes
Practical considerations for consistency and tolerability. Use new sterile syringes for each injection; dispose in a sharps container. Rotate injection sites (abdomen, thighs, upper arms) weekly to reduce local irritation. Gradual dose escalation minimizes gastrointestinal side effects such as nausea [4] [6]. Document weekly dose, injection site, and any adverse effects to maintain consistency. For maintenance doses requiring >1.0 mL, ensure you have appropriately sized syringes (3 mL).
Single peptide protocol reference : Available for related research, development or formulation inquiry workflows.: Available for related research, development or formulation inquiry workflows.
Reconstitution and handling reference : Available for related research, development or formulation inquiry workflows.: Available for related research, development or formulation inquiry workflows.
Research-use documentation inquiry : Available for related research, development or formulation inquiry workflows.: Available for related research, development or formulation inquiry workflows.
Peptide Vials (Cagrilintide, 5 mg each): 8 weeks ≈ 4 vials (17.4 mg total)
12 weeks ≈ 8 vials (35.4 mg total)
16 weeks ≈ 11 vials (53.4 mg total)
Syringes: Weeks 1–4 (doses ≤72 units): U‑100 insulin syringes work well
Weeks 5+ (doses >100 units): 3 mL syringes with 25–27G subcutaneous needles
Per week: 1 syringe
8 weeks: 8 syringes
12 weeks: 12 syringes
16 weeks: 16 syringes
Bacteriostatic Water (10 mL bottles): Use 3.0 mL per vial for reconstitution. 8 weeks (4 vials): 12 mL → 2 × 10 mL bottles
12 weeks (8 vials): 24 mL → 3 × 10 mL bottles
16 weeks (11 vials): 33 mL → 4 × 10 mL bottles
Alcohol Swabs: One for the vial stopper + one for the injection site each week. Per week: 2 swabs
8 weeks: 16 swabs
12 weeks: 24 swabs
16 weeks: 32 swabs → recommend 1 × 100‑count box
Send product, purity, quantity, destination and documentation requirements. Our team will follow up through online consultation or email.
WhatsApp: +852 52102460 +1 4422847013
Address: Huangpu District, Guangzhou, China